Banking human umbilical cord-derived mesenchymal stromal cells for clinical use

Cell Transplantation

Volumn 21, Issue 1, 2012, Pages 207-216

  Gong, Wei ^a   Han, Zhibo ^b   Zhao, Hui ^a,c   Wang, Youwei ^a   Wang, Jiming ^a   Zhong, Jian ^a   Wang, Bin ^a   Wang, Shanshan ^a   Wang, Yongjuan ^a   Sun, Lingyun ^d   Han, Zhongchao ^a,b  

^a AmCellGene Co Ltd   (China)

^b INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^c TIANJIN UNIVERSITY OF COMMERCE   (China)

^d THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

Bank; Graft versus host disease; Mesenchymal stem cells; Multiple sclerosis; Umbilical cord

Indexed keywords

5' NUCLEOTIDASE; CD11B ANTIGEN; CD19 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; ENDOTOXIN; HLA DR ANTIGEN; THY 1 ANTIGEN;

ADIPOGENESIS; ARTICLE; BANK; BONE DEVELOPMENT; CELL ADHESION; CELL DIFFERENTIATION; CELL STRUCTURE; CONTROLLED STUDY; DONOR; DONOR SELECTION; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; MULTIPOTENT STEM CELL; PATIENT SAFETY; PRESERVATION AND STORAGE; PRIORITY JOURNAL; STANDARDIZATION; UMBILICAL CORD BLOOD; UMBILICAL CORD DERIVED MESENCHYMAL STROMAL CELL;

ADULT; BIOLOGICAL SPECIMEN BANKS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CORD BLOOD STEM CELL TRANSPLANTATION; CRYOPRESERVATION; FEMALE; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; UMBILICAL CORD;

BACTERIA (MICROORGANISMS); MYCOPLASMA;

EID: 84863229604     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368911X586756     Document Type: Article

References (34)

1. Baksh, D.; Yao, R.; Tuan, R. S. Comparison of prolifera- tive and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25(6):1384-1392; 2007.
2. Bernardo, M. E.; Zaffaroni, N.; Novara, F.; Cometa, A. M.; Avanzini, M. A.; Moretta, A.; Montagna, D.; Maccario, R.; Villa, R.; Daidone, M. G.; Zuffardi, O.; Locatelli, F. Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res. 67(19):9142-9149; 2007.
3. Caplan, A. I. Mesenchymal stem cells. J. Orthop. Res. 9(5):641-650; 1991.
4. Chapel, A.; Bertho, J. M.; Bensidhoum, M.; Fouillard, L.; Young, R. G.; Frick, J.; Demarquay, C.; Cuvelier, F.; Mathieu, E.; Trompier, F.; Dudoignon, N.; Germain, C.; Mazurier, C.; Aigueperse, J.; Borneman, J.; Gorin, N. C.; Gourmelon, P.; Thierry, D. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syn- drome. J. Gene Med. 5(12):1028-1038; 2003.
5. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F. C.; Krause, D. S.; Deans, R. J.; Keating, A.; Prockop, D. J.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315-317; 2006.
6. Fan, C. G.; Tang, F. W.; Zhang, Q. J.; Lu, S. H.; Liu, H. Y.; Zhao, Z. M.; Liu, B.; Han, Z. B.; Han, Z. C. Characteriza- tion and neural differentiation of fetal lung mesenchymal stem cells. Cell Transplant. 14(5):311-321; 2005.
7. Friedenstein, A. J.; Piatetzky-Shapiro, I. I.; Petrakova, K. V. Osteogenesis in transplants of bone marrow cells. J. Embryol. Exp. Morphol. 16(3):381-390; 1966.
8. Garcia-Olmo, D.; Herreros, D.; Pascual, I.; Pascual, J. A.; Del-Valle, E.; Zorrilla, J.; De-La-Quintana, P.; Garcia- Arranz, M.; Pascual, M. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: A phase II clinical trial. Dis. Colon Rectum 52(1):79-86; 2009.
9. Gonzalez, R.; Griparic, L.; Umana, M.; Burgee, K.; Vargas, V.; Nasrallah, R.; Silva, F.; Patel, A. An efficient approach to isolation and characterization of pre- and postnatal umbilical cord lining stem cells for clinical applications. Cell Transplant. 19(11):1439-1449; 2010.
10. Hare, J. M.; Traverse, J. H.; Henry, T. D.; Dib, N.; Strumpf, R. K.; Schulman, S. P.; Gerstenblith, G.; DeMaria, A. N.; Denktas, A. E.; Gammon, R. S.; Hermiller, J. B.; Reisman, M. A.; Schaer, G. L.; Sherman, W. A random-ized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54(24):2277-2286; 2009.
11. Horwitz, E. M.; Prockop, D. J.; Fitzpatrick, L. A.; Koo, W. W.; Gordon, P. L.; Neel, M.; Sussman, M.; Orchard, P.; Marx, J. C.; Pyeritz, R. E.; Brenner, M. K. Transplant- ability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imper- fecta. Nat. Med. 5(3):309-313; 1999.
12. Hung, H. S.; Shyu, W. C.; Tsai, C. H.; Hsu, S. H.; Lin, S. Z. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases. Cell Transplant. 18(9):1003-1012; 2009.
13. Ishige, I.; Nagamura-Inoue, T.; Honda, M. J.; Harnprasopwat, R.; Kido, M.; Sugimoto, M.; Nakauchi, H.; Tojo, A. Com- parison of mesenchymal stem cells derived from arterial, venous, and Wharton's jelly explants of human umbilical cord. Int. J. Hematol. 90(2):261-269; 2009.
14. Karahuseyinoglu, S.; Cinar, O.; Kilic, E.; Kara, F.; Akay, G. G.; Demiralp, D. O.; Tukun, A.; Uckan, D.; Can, A. Biology of stem cells in human umbilical cord stroma: In situ and in vitro surveys. Stem Cells 25(2):319-331; 2007.
15. Kebriaei, P.; Isola, L.; Bahceci, E.; Holland, K.; Rowley, S.; McGuirk, J.; Devetten, M.; Jansen, J.; Herzig, R.; Schuster, M.; Monroy, R.; Uberti, J. Adult human mesen- chymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol. Blood Marrow Transplant. 15(7):804-811; 2009.
16. Koc, O. N.; Gerson, S. L.; Cooper, B. W.; Dyhouse, S. M.; Haynesworth, S. E.; Caplan, A. I.; Lazarus, H. M. Rapid hematopoietic recovery after coinfusion of autologous- blood stem cells and culture-expanded marrow mesenchy- mal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J. Clin. Oncol. 18(2):307-316; 2000.
17. Le Blanc, K.; Frassoni, F.; Ball, L.; Locatelli, F.; Roelofs, H.; Lewis, I.; Lanino, E.; Sundberg, B.; Bernardo, M. E.; Remberger, M.; Dini, G.; Egeler, R. M.; Bacigalupo, A.; Fibbe, W.; Ringden, O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371(9624):1579-1586; 2008.
18. Le Blanc, K.; Rasmusson, I.; Sundberg, B.; Götherström, C.; Hassan, M.; Uzunel, M.; Ringden, O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363(9419): 1439-1441; 2004.
19. Le Blanc, K.; Tammik, C.; Rosendahl, K.; Zetterberg, E.; Ringden, O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp. Hematol. 31(10):890-896; 2003.
20. Lee, P. H.; Kim, J. W.; Bang, O. Y.; Ahn, Y. H.; Joo, I. S.; Huh, K. Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin. Pharmacol. Ther. 83(5):723-730; 2008.
21. Li, G.; Zhang, X. A.; Wang, H.; Wang, X.; Meng, C. L.; Chan, C. Y.; Yew, D. T.; Tsang, K. S.; Li, K.; Tsai, S. N.; Ngai, S. M.; Han, Z. C.; Lin, M. C.; He, M. L.; Kung, H. F. Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: Implication in the migration. Proteomics 9(1):20-30; 2009.
22. Liang, J.; Zhang, H.; Hua, B.; Wang, H.; Wang, J.; Han, Z.; Sun, L. Allogeneic mesenchymal stem cells transplan- tation in treatment of multiple sclerosis. Mult. Scler. 15(5):644-646; 2009.
23. Lu, D. P.; Dong, L.; Wu, T.; Huang, X. J.; Zhang, M. J.; Han, W.; Chen, H.; Liu, D. H.; Gao, Z. Y.; Chen, Y. H.; Xu, L. P.; Zhang, Y. C.; Ren, H. Y.; Li, D.; Liu, K. Y. Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable out- comes with HLA-identical sibling transplantation. Blood 107(8):3065-3073; 2006.
24. Lu, L. L.; Liu, Y. J.; Yang, S. G.; Zhao, Q. J.; Wang, X.; Gong, W.; Han, Z. B.; Xu, Z. S.; Lu, Y. X.; Liu, D.; Chen, Z. Z.; Han, Z. C. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoie-sis-supportive function and other potentials. Haematologica 91(8):1017-1026; 2006.
25. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284(5411): 143-147; 1999.
26. Reinisch, A.; Strunk, D. Isolation and animal serum free expansion of human umbilical cord derived mesenchymal stromal cells (MSCs) and endothelial colony forming pro- genitor cells (ECFCs). J. Vis. Exp. 32:1525; 2009.
27. Ringden, O.; Uzunel, M.; Rasmusson, I.; Remberger, M.; Sundberg, B.; Lonnies, H.; Marschall, H. U.; Dlugosz, A.; Szakos, A.; Hassan, Z.; Omazic, B.; Aschan, J.; Barkholt, L.; Le Blanc, K. Mesenchymal stem cells for treatment of therapy-resistant graft-versus host disease. Transplantation 81(10):1390-1397; 2006.
28. Romanov, Y. A.; Svintsitskaya, V. A.; Smirnov, V. N. Searching for alternative sources of postnatal human mes-enchymal stem cells: Candidate MSC-like cells from umbilical cord. Stem Cells 21(1):105-110; 2003.
29. Røsland, G. V.; Svendsen, A.; Torsvik, A.; Sobala, E.; McCormack, E.; Immervoll, H.; Mysliwietz, J.; Tonn, J. C.; Goldbrunner, R.; Lønning, P. E.; Bjerkvig, R.; Schichor, C. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spon- taneous malignant transformation. Cancer Res. 69(13): 5331-5339; 2009.
30. Rubio, D.; Garcia-Castro, J.; Martin, M. C.; de la Fuente, R.; Cigudosa, J. C.; Lloyd, A. C.; Bernad, A. Spontaneous human adult stem cell transformation. Cancer Res. 65(8): 3035-3039; 2005.
31. Secco, M.; Moreira, Y. B.; Zucconi, E.; Vieira, N. M.; Jazedje, T.; Muotri, A. R.; Okamoto, O. K.; Verjovski- Almeida, S.; Zatz, M. Gene expression profile of mesen- chymal stem cells from paired umbilical cord units: Cord is different from blood. Stem Cell Rev. 5(4):387-401; 2009.
32. Sun, L.; Wang, D.; Liang, J.; Zhang, H.; Feng, X.; Wang, H.; Hua, B.; Liu, B.; Ye, S.; Hu, X.; Xu, W.; Zeng, X.; Hou, Y.; Gilkeson, G. S.; Silver, R. M.; Lu, L.; Shi, S. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 62(8):2467-2475; 2010.
33. Sundin, M.; Ringden, O.; Sundberg, B.; Nava, S.; Götherström, C.; Le Blanc, K. No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum anti- bodies, after transplantation in allogeneic hematopoietic stem cell recipients. Haematologica 92(9):1208-1215; 2007.
34. Weber, D. J. Manufacturing considerations for clinical uses of therapies derived from stem cells. Methods Enzy- mol. 420:410-430; 2006.